March 19, 2022 PAO-03-22-R250-15
As the Pharma's Almanac team made their way through Montana on the Road to 50 States, Thomas Hughes, Chief Scientific Officer at Montana Molecular, talks to Nigel about the challenges of the pandemic and the company's expertise in fluorescent biosensensors.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.
Montana Molecular develops genetically encoded fluorescent biosensors and probes for cell-based assays and live cell imaging. Our products are used for drug discovery and to observe and measure cell signaling processes. Our scientific team is focused on creating breakthrough innovations that empower both basic research scientists and drug discovery teams.